id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0286-0017,FDA,FDA-2013-D-0286,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry: Formal Meetings Between the Food and Drug Administration and Biosimilar Biological Product Sponsors or Applicants",Notice,30 Day Proposed Information Collection,2018-09-11T04:00:00Z,2018,9,2018-09-11T04:00:00Z,2018-10-12T03:59:59Z,2018-09-11T14:09:54Z,2018-19674,0,0,09000064836d3b8c
FDA-2013-D-0286-0016,FDA,FDA-2013-D-0286,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Formal Meetings Between the Food and Drug Administration and Biosimilar Biological Product Sponsors or Applicants,Notice,60 Day Proposed Information Collection,2018-06-18T04:00:00Z,2018,6,2018-06-18T04:00:00Z,2018-08-18T03:59:59Z,2018-06-18T14:08:14Z,2018-12968,0,0,090000648342494e